KORPHARM CO LTD has a total of 11 patent applications. It decreased the IP activity by 62.0%. Its first patent ever was published in 2017. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and organic fine chemistry are ZHEN AO GROUP CO LTD, MFC CO LTD and GUEULRI.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Republic of Korea | 2 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Foods | |
#2 | Medical preparations | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Therapeutic chemical compounds | |
#5 | Special foods | |
#6 | Organic chemistry methods | |
#7 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Park Gil Hong | 10 |
#2 | Hong Seong Su | 5 |
#3 | Choi Yun Hyeok | 5 |
#4 | Song Da Woon | 5 |
#5 | Lee Jung Hun | 5 |
#6 | Choi Min Ji | 5 |
#7 | Ku Jin Mo | 5 |
#8 | Choi Chun Whan | 5 |
#9 | Kim Myung Hwan | 4 |
#10 | Md Yousof Ali | 3 |
Publication | Filing date | Title |
---|---|---|
CN110996930A | Novel benzylidene acetone derivative and use thereof | |
EP3639817A1 | Compositions containing pterosin compound and derivatives thereof active ingredients for prevention or treatment of degenerative brain diseases | |
WO2018062895A1 | Composition comprising osmundacetone or pharmaceutically acceptable salt thereof for preventing or treating bone disease | |
KR20190015942A | Compound preventing and treating of bone disease and Use therof | |
KR20190012556A | Novel benzylideneacetone derivatives and uses thereof |